Experimental Pharmacological Research of New Combined Medicinal Product for Treatment of Sensorineural Hearing Loss
Sergiu Parii✉, Livia Uncu, Adrian Sochirca, Alina Ungureanu, Vasile Cabac, Vladimir Valica
Received 22 October 2026 · Accepted 26 October 2026 · Published 26 October 2026 · Corrected 9 November 2026
DOI: https://doi.org/10.5281/zenodo.23675415
Article PDF · Original poster (PDF)
- views
- 31
- downloads
- 11
- countries
- 6
Since publication · journal site and Zenodo archive · robots excluded
Key messages
- A novel fixed-dose combination capsule containing nicergoline, piracetam, and hawthorn extract shows otoprotective effects in gentamicin-induced sensorineural hearing loss models.
- Preclinical audiological and vestibular tests demonstrated significant benefits of the combined medicinal product with no notable side effects.
- The study supports further preclinical and clinical research for this combined drug in the treatment of sensorineural hearing loss and peripheral vestibulopathy.
Abstract
Introduction
Sensorineural hearing loss (SHL) affects the perception of sounds from the inner ear, auditory nerve, subcortical, and cortical auditory centers. The drug treatment of SHL is usually symptomatic and includes vasodilators, steroids, nootropics, and antioxidants.
Materials and methods
The research algorithm consists of establishing the method for inducing SHL and peripheral vestibulopathy (gentamicine); experimental audiometric methods (otoacoustic emissions, Preyer reflex) for monitoring SHL; preclinical testing of static and dynamic locomotor coordination in Wistar rats (open field test, horizontal walking, and forced motor activity test to maintain balance). All procedures describing experiments involving laboratory animals were conducted in accordance with Directive 2010/63/EU and national Law no. 211/2017.
Results
The test product demonstrated low acute toxicity across administration routes (ATC 5). In gentamicin-induced SHL models, animals treated with the test product showed a clear otoprotective effect, evidenced by improved otoacoustic emission results (Transitory OAE, Distortion Product OAE > 0 dB SPL; signal-to-noise ratio > 3 dB Sound Pressure Level in the 1000–4000 Hz range), and Preyer reflex at 80 dB SL in contrast to the untreated ototoxicity group (p < 0.05). Preclinical research in audiology and experimental vestibulometry demonstrated the beneficial effect of the studied product in the complex treatment of SHL and peripheral vestibular disorders (using OEA, Cat Walk, Rota Rod Tests). The fixed-dose medicinal product therapy yielded the most significant benefits, with no notable side effects observed.
Conclusion
This study pharmacologically characterized a novel combined drug in capsules containing nicergoline, piracetam, and hawthorn extract, for potential use in SHL therapy. The data of experimental audiological and vestibular tests in rats encourage further preclinical and clinical research.
Original poster
References
- Hongzhuo L., Jinsong H., Kevin S.Li. Current strategies for drug delivery to the inner ear. Acta Pharmaceutica Sinica B. 2013; 3(2):86–96. https://doi.org/10.1016/j.apsb.2013.02.003
- Chennaq, M., Aliat, Z., Elmedkouri, S., Chefchaouni, A. C., Ou-Kheda, N., Fahry, A., ... & Rahali, Y. (2026). Galenic Stability of Propofol Emulsions After Expiry: Assessment After 3 Years. Research Journal of Pharmacy and Technology, 19(1), 215-222.
- Rus L.M., Uncu A., Parii S. et al. Development and Preclinical Evaluation of Fixed-Dose Capsules Containing Nicergoline, Piracetam, and Hawthorn Extract for Sensorineural Hearing Loss. Pharmaceutics. 2025; 17(8):1-25. https://doi.org/10.3390/pharmaceutics17081017
Related posters
Pharmacology & TherapeuticsAI-Powered Ligand-Based Design Targeting YCK1 and YCK2 in Saccharomyces cerevisiae: Implications for Modulating Kinase Signaling Pathways in Drug DiscoveryS. Harrizi, Y. Zaidoune, R. Amal and 5 others
Pharmacology & TherapeuticsImplementation of experimental audiometry and vestibulometry in the preclinical research of medicinal productsS. Parii, E. Nicolai, A. Sochirca and 4 others
Pharmacology & TherapeuticsPhytopharmaceutical and Impacts of Utilizing Piper betle leaf in Treating Leucorrhoea: Literature ReviewY. Jung, K. Thiotansen, S. Debora and 1 other
Pharmacology & TherapeuticsHarnessing Hyssopus officinalis stems to counteract gastric mucosal injuries: A novel phytotherapeutic avenueN. Hamoud, Z. Maammeri